- P. Waffo-Téguo, S. Krisa, A. D. Pawlus, T. Richard, J. P. Monti and J. M. Mérillon: Grapevine stilbenoids: Bioavailability and neuroprotection Springer Berlin Heidelberg.
- Almeida L, Vaz-da-Silva M, Falcao A, Soares E, Costa R, Loureiro AI, Fernandes-Lopes C, Rocha JF, Nunes T, Wright L, Soares-da-Silva P: Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res. 2009 May;53 Suppl 1:S7-15. doi: 10.1002/mnfr.200800177. [PubMed:19194969 ]
- Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE: Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1246-52. [PubMed:17548692 ]
- Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE: Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 2010 Nov 15;70(22):9003-11. doi: 10.1158/0008-5472.CAN-10-2364. Epub 2010 Oct 8. [PubMed:20935227 ]
- Goldberg DM, Yan J, Soleas GJ: Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem. 2003 Feb;36(1):79-87. doi: 10.1016/s0009-9120(02)00397-1. [PubMed:12554065 ]
- Nunes T, Almeida L, Rocha JF, Falcao A, Fernandes-Lopes C, Loureiro AI, Wright L, Vaz-da-Silva M, Soares-da-Silva P: Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects. J Clin Pharmacol. 2009 Dec;49(12):1477-82. doi: 10.1177/0091270009339191. Epub 2009 Oct 1. [PubMed:19797536 ]
- J. Ortuno, M. I. Covas, M. Farre, M. Pujadas, M. Fito, O. Khymenets, et al.: Matrix effects on the bioavailability of resveratrol in humans Food Chemistry. 2010 June 15;120(4):1123-1130.
- Sergides C, Chirila M, Silvestro L, Pitta D, Pittas A: Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers. Exp Ther Med. 2016 Jan;11(1):164-170. doi: 10.3892/etm.2015.2895. Epub 2015 Nov 25. [PubMed:26889234 ]
- Springer M, Moco S: Resveratrol and Its Human Metabolites-Effects on Metabolic Health and Obesity. Nutrients. 2019 Jan 11;11(1). pii: nu11010143. doi: 10.3390/nu11010143. [PubMed:30641865 ]
- Tani H, Hikami S, Iizuna S, Yoshimatsu M, Asama T, Ota H, Kimura Y, Tatefuji T, Hashimoto K, Higaki K: Pharmacokinetics and safety of resveratrol derivatives in humans after oral administration of melinjo (Gnetum gnemon L.) seed extract powder. J Agric Food Chem. 2014 Feb 26;62(8):1999-2007. doi: 10.1021/jf4048435. Epub 2014 Feb 12. [PubMed:24495149 ]
- Wang P, Sang S: Metabolism and pharmacokinetics of resveratrol and pterostilbene. Biofactors. 2018 Jan;44(1):16-25. doi: 10.1002/biof.1410. Epub 2018 Jan 8. [PubMed:29315886 ]
- Smoliga JM, Blanchard O: Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution? Molecules. 2014 Oct 24;19(11):17154-72. doi: 10.3390/molecules191117154. [PubMed:25347459 ]
- Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK: High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004 Dec;32(12):1377-82. Epub 2004 Aug 27. [PubMed:15333514 ]
- Ferraz da Costa DC, Pereira Rangel L, Quarti J, Santos RA, Silva JL, Fialho E: Bioactive Compounds and Metabolites from Grapes and Red Wine in Breast Cancer Chemoprevention and Therapy. Molecules. 2020 Aug 1;25(15). pii: molecules25153531. doi: 10.3390/molecules25153531. [PubMed:32752302 ]